{
    "nct_id": "NCT06456463",
    "official_title": "A Phase II Multicenter Open-label Trial of Tagraxofusp (Tag) in Combination With Venetoclax and Azacitidine (Ven/Aza) in Adults With Previously Untreated CD123+ Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy",
    "inclusion_criteria": "* Previously untreated with histological confirmation of AML by World Health Organization 2022 criteria and are ineligible for treatment with a standard cytarabine and anthracycline induction regimen due to age, or comorbidity.\n* Participant has any level of CD123 expression on blasts confirmed centrally by flow cytometry.\n* Must be considered ineligible for intensive chemotherapy, defined by the following:\n\n  * ≥75 years of age; or\n  * ≥18 to 74 years of age with at least 1 of the following comorbidities:\n\n    * Eastern Cooperative Oncology Group (ECOG) performance status of 2 or 3.\n    * Diffusing capacity of the lung for carbon monoxide of ≤65% or forced expiratory volume in 1 second ≤65%.\n    * Baseline creatinine clearance ≥30 to <45 milliliters/minute calculated by the Cockcroft Gault formula or measured by 24-hour urine collection.\n    * Hepatic disorder with total bilirubin >1.5 x upper limit of normal.\n    * Any other comorbidity that the investigator judges to be incompatible with intensive chemotherapy must be reviewed and approved by the Sponsor.\n* ECOG performance status:\n\n  * 0 to 2 for participants ≥75 years of age, or\n  * 0 to 3 for participants ≥18 to 74 years of age.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participant has received prior therapy for AML.\n* Willing and able to receive standard induction therapy.\n* Treatment for an antecedent hematologic disease with a hypomethylating agent, venetoclax, tagraxofusp, purine analogue, cytarabine, intensive chemotherapy, chimeric antigen receptor-T therapy, or other experimental therapies.\n* AML with central nervous system involvement.\n\nNote: Other inclusion/exclusion criteria may apply.",
    "miscellaneous_criteria": "Key"
}